120 related articles for article (PubMed ID: 34193503)
1. PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.
Mollerup A; Larsen SC; Bennetzen AS; Henriksen M; Simonsen MK; Weis N; Kofod LM; Heitmann BL
BMJ Open; 2021 Jun; 11(6):e050582. PubMed ID: 34193503
[TBL] [Abstract][Full Text] [Related]
2. Effect of PEP flute self-care versus usual care in early covid-19: non-drug, open label, randomised controlled trial in a Danish community setting.
Mollerup A; Henriksen M; Larsen SC; Bennetzen AS; Simonsen MK; Kofod LM; Knudsen JD; Nielsen XC; Weis N; Heitmann BL
BMJ; 2021 Nov; 375():e066952. PubMed ID: 34819329
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
4. Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial.
Tan DHS; Chan AK; Jüni P; Tomlinson G; Daneman N; Walmsley S; Muller M; Fowler R; Murthy S; Press N; Cooper C; Lee T; Mazzulli T; McGeer A
Trials; 2021 Mar; 22(1):224. PubMed ID: 33752741
[TBL] [Abstract][Full Text] [Related]
5. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
6. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V;
Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163
[TBL] [Abstract][Full Text] [Related]
8. ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19.
McCafferty K; Hollowood Z; Allen M; Lockhart D; Chorlton J; Martin J
BMJ Open; 2021 Dec; 11(12):e049650. PubMed ID: 34853102
[TBL] [Abstract][Full Text] [Related]
9. Prevention of SARS-CoV-2 (COVID-19) transmission in residential aged care using ultraviolet light (PETRA): a two-arm crossover randomised controlled trial protocol.
Brass A; Shoubridge AP; Crotty M; Morawska L; Bell SC; Qiao M; Woodman RJ; Whitehead C; Inacio MC; Miller C; Corlis M; Larby N; Elms L; Sims SK; Taylor SL; Flynn E; Papanicolas LE; Rogers GB
BMC Infect Dis; 2021 Sep; 21(1):967. PubMed ID: 34535091
[TBL] [Abstract][Full Text] [Related]
10. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies.
van Haren FMP; Richardson A; Yoon HJ; Artigas A; Laffey JG; Dixon B; Smith R; Vilaseca AB; Barbera RA; Ismail TI; Mahrous RS; Badr M; De Nucci G; Sverdloff C; van Loon LM; Camprubi-Rimblas M; Cosgrave DW; Smoot TL; Staas S; Sann K; Sas C; Belani A; Hillman C; Shute J; Carroll M; Wilkinson T; Carroll M; Singh D; Page C
Br J Clin Pharmacol; 2021 Aug; 87(8):3075-3091. PubMed ID: 33377218
[TBL] [Abstract][Full Text] [Related]
11. COVID-NURSE: evaluation of a fundamental nursing care protocol compared with care as usual on experience of care for noninvasively ventilated patients in hospital with the SARS-CoV-2 virus-protocol for a cluster randomised controlled trial.
Richards DA; Sugg HV; Cockcroft E; Cooper J; Cruickshank S; Doris F; Hulme C; Logan P; Iles-Smith H; Melendez-Torres GJ; Rafferty AM; Reed N; Russell AM; Shepherd M; Singh SJ; Thompson Coon J; Tooze S; Wootton S; Abbott R; Bethel A; Creanor S; Quinn L; Tripp H; Warren FC; Whear R; Bollen J; Hunt HA; Kent M; Morgan L; Morley N; Romanczuk L
BMJ Open; 2021 May; 11(5):e046436. PubMed ID: 34039574
[TBL] [Abstract][Full Text] [Related]
12. Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise-CISCO-21.
Morrow A; Gray SR; Bayes HK; Sykes R; McGarry E; Anderson D; Boiskin D; Burke C; Cleland JGF; Goodyear C; Ibbotson T; Lang CC; McConnachie ; Mair F; Mangion K; Patel M; Sattar N; Taggart D; Taylor R; Dawkes S; Berry C
Trials; 2022 Aug; 23(1):660. PubMed ID: 35971155
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
Adriaenssens N; Scholtes B; Bruyndonckx R; Verbakel JY; De Sutter A; Heytens S; Van den Bruel A; Desombere I; Van Damme P; Goossens H; Buret L; Duysburgh E; Coenen S
BMJ Open; 2022 Jan; 12(1):e054688. PubMed ID: 35105642
[TBL] [Abstract][Full Text] [Related]
14. Helmet Non-Invasive Ventilation for COVID-19 Patients (Helmet-COVID): study protocol for a multicentre randomised controlled trial.
Arabi YM; Tlayjeh H; Aldekhyl S; Al-Dorzi HM; Abdukahil SA; Al Harbi MK; Al Haji H; Al Mutairi M; Al Zumai O; Al Qasim E; Al Wehaibi W; Al Qahtani S; Al-Hameed F; Chalabi J; Alshahrani M; Albrahim T; Alharthy A; Mady A; Bin Eshaq A; Al Bshabshe AA; Al Aseri Z; Al Duhailib Z; Kharaba A; Alqahtani R; Al Ghamdi A; Altalag A; Alghamdi K; Almaani M; Algethamy H; Al Aqeily A; Al Baseet F; Al Samannoudi H; Al Obaidi M; Ismaiel YT; Al-Fares AA
BMJ Open; 2021 Aug; 11(8):e052169. PubMed ID: 34446500
[TBL] [Abstract][Full Text] [Related]
15. CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults.
Veenith T; Fisher BA; Slade D; Rowe A; Sharpe R; Thickett DR; Whitehouse T; Rowland M; Scriven J; Parekh D; Bowden SJ; Savage JS; Richards D; Bion J; Kearns P; Gates S; ;
BMJ Open; 2021 Nov; 11(11):e050202. PubMed ID: 34764169
[TBL] [Abstract][Full Text] [Related]
16. PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients-study protocol for a randomised controlled trial.
Karsten MM; Kühn F; Pross T; Blohmer JU; Hage AM; Fischer F; Rose M; Grittner U; Gebert P; Ferencz J; Pauler L; Breidenbach C; Kowalski C;
Trials; 2021 Sep; 22(1):666. PubMed ID: 34583744
[TBL] [Abstract][Full Text] [Related]
17. Effects of 3 months of multi-nutrient supplementation on the immune system and muscle and respiratory function of older adults in aged care (The Pomerium Study): protocol for a randomised controlled trial.
Al Saedi A; Kirk B; Iuliano S; Zanker J; Vogrin S; Jayaram L; Thomas S; Golding C; Navarro-Perez D; Marusic P; Leng S; Nanan R; Duque G
BMJ Open; 2022 May; 12(5):e059075. PubMed ID: 35523505
[TBL] [Abstract][Full Text] [Related]
18. The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium.
Daynes E; Baldwin M; Greening NJ; Yates T; Bishop NC; Mills G; Roberts M; Hamrouni M; Plekhanova T; Vogiatzis I; Echevarria C; Nathu R; McAuley HJC; Latimer L; Glennie J; Chambers F; Penfold R; Hume E; Megaritis D; Alexiou C; Potthoff S; Hogg MJ; Haighton C; Nichol B; Leavy OC; Richardson M; Elneima O; Singapuri A; Sereno M; Saunders RM; Harris VC; Nolan CM; Bolton C; Houchen-Wolloff L; Harrison EM; Lone N; Quint J; Chalmers JD; Ho LP; Horsley A; Marks M; Poinasamy K; Ramen B; Wain LV; Brightling C; Man WD; Evans R; Singh SJ
Trials; 2023 Jan; 24(1):61. PubMed ID: 36703183
[TBL] [Abstract][Full Text] [Related]
19. Statistical analysis plan for a pragmatic phase III randomised controlled trial examining behaviour change physiotherapy intervention to increase physical activity following hip and knee replacements: the PEP-TALK trial.
Ooms A; Dutton SJ; Parsons S; Fordham B; Hing C; Lamb S; Smith T
Trials; 2021 Jul; 22(1):467. PubMed ID: 34284802
[TBL] [Abstract][Full Text] [Related]
20. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial).
Pittet LF; Messina NL; Gardiner K; Orsini F; Abruzzo V; Bannister S; Bonten M; Campbell JL; Croda J; Dalcolmo M; Elia S; Germano S; Goodall C; Gwee A; Jamieson T; Jardim B; Kollmann TR; Guimarães Lacerda MV; Lee KJ; Legge D; Lucas M; Lynn DJ; McDonald E; Manning L; Munns CF; Perrett KP; Prat Aymerich C; Richmond P; Shann F; Sudbury E; Villanueva P; Wood NJ; Lieschke K; Subbarao K; Davidson A; Curtis N;
BMJ Open; 2021 Oct; 11(10):e052101. PubMed ID: 34711598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
